Paralel Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Hold
19,417
0.17% 32
2025
Q4
$3.99M Hold
19,417
0.16% 33
2025
Q3
$3.05M Buy
19,417
+25
+0.1% +$3.86K 0.12% 44
2025
Q2
$3.26M Sell
19,392
-3,091
-14% -$459K 0.13% 32
2025
Q1
$3.1M Hold
22,483
0.13% 37
2024
Q4
$2.66M Buy
22,483
+2,040
+10% +$238K 0.11% 52
2024
Q3
$2.26M Hold
20,443
0.1% 70
2024
Q2
$2.01M Buy
+20,443
New +$2.08M 0.1% 75
2023
Q2
Sell
-32,030
Closed -$2.42M 83
2023
Q1
$2.42M Buy
32,030
+842
+3% +$63.5K 0.14% 26
2022
Q4
$2.4M Buy
+31,188
New +$2.37M 0.14% 22

Other funds holding CAH

Paralel Advisors's CAH Position: Q1 2026 in Review

Paralel Advisors held its Cardinal Health (CAH) position steady in Q1 2026 at 19,417 shares worth $4.1M. The position accounts for 0.17% of the portfolio, ranked #32.

Paralel Advisors first reported a position in CAH in Q4 2022 and has held it in 10 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Paralel Advisors held 19,417 shares of Cardinal Health worth $4.1M as of Q1 2026.
  • Paralel Advisors left its Cardinal Health share count unchanged in Q1 2026.
  • Cardinal Health made up 0.17% of Paralel Advisors's portfolio in Q1 2026, its #32 holding.
  • Paralel Advisors first reported a position in Cardinal Health in Q4 2022 and has held it in 10 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Paralel Advisors's 13F filing for Q1 2026, filed 8 May 2026.